| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3593 |
| Trial ID | NCT06047197 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RC19D2 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Clinical Trial of Dinorencel Injection (or RC19D2 Cell Injection) in the Treatment of CD19-positive Relapsed or Refractory Diffuse Large B-cell Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Beijing Yongtai Ruike Biotechnology Company Ltd |
| Other ID(s) | RC19D2-r/r DLBCL-01 |
| Cohort 1 | |||||||||||
|
|||||||||||